Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,676 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations from primary care physicians, family, friends and work colleagues influence patients' decisions related to hepatitis screening, medical examinations and antiviral treatment.
Okada M, Oeda S, Katsuki N, Iwane S, Kawaguchi Y, Kawamoto S, Tomine Y, Fukuyoshi J, Maeyama K, Tanaka H, Anzai K, Eguchi Y. Okada M, et al. Among authors: kawaguchi y. Exp Ther Med. 2020 Apr;19(4):2973-2982. doi: 10.3892/etm.2020.8533. Epub 2020 Feb 18. Exp Ther Med. 2020. PMID: 32256783 Free PMC article.
Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial.
Iwane S, Mizuta T, Kawaguchi Y, Takahashi H, Oza N, Oeda S, Nakashita S, Kuwashiro T, Otsuka T, Kawazoe S, Eguchi Y, Anzai K, Ozaki I, Fujimoto K. Iwane S, et al. Among authors: kawaguchi y. Intern Med. 2015;54(24):3113-9. doi: 10.2169/internalmedicine.54.5574. Epub 2015 Dec 15. Intern Med. 2015. PMID: 26666596 Free article. Clinical Trial.
An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C.
Takahashi H, Mizuta T, Oeda S, Isoda H, Nakashita S, Kawaguchi Y, Izumi N, Hirai M, Kurose K, Iwane S, Eguchi Y, Kimura S, Anzai K, Ozaki I. Takahashi H, et al. Among authors: kawaguchi y. J Viral Hepat. 2013 Apr;20(4):e124-6. doi: 10.1111/jvh.12026. Epub 2012 Dec 10. J Viral Hepat. 2013. PMID: 23490380
Efficacy of ezetimibe for reducing serum low-density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non-alcoholic fatty liver disease.
Oza N, Takahashi H, Eguchi Y, Kitajima Y, Kuwashiro T, Ishibashi E, Nakashita S, Iwane S, Kawaguchi Y, Mizuta T, Ozaki I, Ono N, Eguchi T, Fujimoto K, Anzai K. Oza N, et al. Among authors: kawaguchi y. Hepatol Res. 2014 Jul;44(7):812-7. doi: 10.1111/hepr.12176. Epub 2013 Jun 25. Hepatol Res. 2014. PMID: 23721476
2,676 results